Saturday, September 08, 2018 7:25:22 PM
Tony - I have few people here on the board who's judgement I trust , and you are one of them.
No , I am not talking medical judgement , I trust myself here , but all this business stuff which I don't even want to think about !!!
OK , personally I trust Dr P. , what he did with Pro 140 is unbelievable !!!
Now , in business I start to have a questions together with most of you...
During CC July 17 , Dr P said no more of all this bad loans , and August 2 we learned here on the board from Beeandhc123 that Paulson is looking for investors with warrants !!!
It is still hard for me to forget that , 2 weeks later ....
but I am a VERY big believer in Pro 140 , so I try to put other things to the back !!!!
Now GvHd ,- when during last CC I asked Dr P about GvHD he answered very nicely , he said , doctors in all 5 centers think that they will not have a problem with enrollment ,
so , if this is a case we should have results within few weeks , what a big deal to have 10 patients then ...!!??
I never blamed Dr P for " Golden Q " it was out of his control, I know that, I been there in medicine !!!!
but I agree , he should have better time of projection with expenses,
enrollments is not up to him...
and I dont like 600,000 AS , but I will wait for explanation, and I hope explanation is coming .
Without good explanation like JPValas I will vote no.
No , I am not talking medical judgement , I trust myself here , but all this business stuff which I don't even want to think about !!!
OK , personally I trust Dr P. , what he did with Pro 140 is unbelievable !!!
Now , in business I start to have a questions together with most of you...
During CC July 17 , Dr P said no more of all this bad loans , and August 2 we learned here on the board from Beeandhc123 that Paulson is looking for investors with warrants !!!
It is still hard for me to forget that , 2 weeks later ....
but I am a VERY big believer in Pro 140 , so I try to put other things to the back !!!!
Now GvHd ,- when during last CC I asked Dr P about GvHD he answered very nicely , he said , doctors in all 5 centers think that they will not have a problem with enrollment ,
so , if this is a case we should have results within few weeks , what a big deal to have 10 patients then ...!!??
I never blamed Dr P for " Golden Q " it was out of his control, I know that, I been there in medicine !!!!
but I agree , he should have better time of projection with expenses,
enrollments is not up to him...
and I dont like 600,000 AS , but I will wait for explanation, and I hope explanation is coming .
Without good explanation like JPValas I will vote no.
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
